Lifevantage Gross Profit 2010-2025 | LFVN

Lifevantage gross profit from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Lifevantage Annual Gross Profit
(Millions of US $)
2024 $159
2023 $170
2022 $168
2021 $182
2020 $195
2019 $188
2018 $168
2017 $166
2016 $173
2015 $162
2014 $181
2013 $172
2012 $108
2011 $33
2010 $10
2009 $0
Lifevantage Quarterly Gross Profit
(Millions of US $)
2025-03-31 $47
2024-12-31 $55
2024-09-30 $38
2024-06-30 $39
2024-03-31 $38
2023-12-31 $41
2023-09-30 $41
2023-06-30 $43
2023-03-31 $43
2022-12-31 $42
2022-09-30 $42
2022-06-30 $42
2022-03-31 $40
2021-12-31 $43
2021-09-30 $44
2021-06-30 $45
2021-03-31 $43
2020-12-31 $49
2020-09-30 $45
2020-06-30 $50
2020-03-31 $47
2019-12-31 $51
2019-09-30 $47
2019-06-30 $46
2019-03-31 $47
2018-12-31 $48
2018-09-30 $46
2018-06-30 $46
2018-03-31 $42
2017-12-31 $40
2017-09-30 $40
2017-06-30 $42
2017-03-31 $37
2016-12-31 $41
2016-09-30 $46
2016-06-30 $44
2016-03-31 $46
2015-12-31 $44
2015-09-30 $38
2015-06-30 $38
2015-03-31 $38
2014-12-31 $41
2014-09-30 $46
2014-06-30 $47
2014-03-31 $47
2013-12-31 $44
2013-09-30 $44
2013-06-30 $44
2013-03-31 $44
2012-12-31 $39
2012-09-30 $45
2012-06-30 $38
2012-03-31 $31
2011-12-31 $22
2011-09-30 $17
2011-06-30 $13
2011-03-31 $8
2010-12-31 $6
2010-09-30 $5
2010-06-30 $4
2010-03-31 $2
2009-12-31 $2
2009-09-30 $2
2009-06-30 $1
2009-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.164B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.020B 21.74
Becton Dickinson (BDX) United States $49.466B 12.25
Cardinal Health (CAH) United States $36.861B 19.31
Labcorp (LH) United States $20.839B 16.90
Straumann Holding AG (SAUHY) Switzerland $20.586B 0.00
West Pharmaceutical Services (WST) United States $15.149B 31.75
Cooper (COO) United States $13.655B 17.60
Align Technology (ALGN) United States $13.115B 26.03
Henry Schein (HSIC) United States $8.519B 14.61
Merit Medical Systems (MMSI) United States $5.616B 27.15
DENTSPLY SIRONA (XRAY) United States $3.185B 9.51
CONMED (CNMD) United States $1.756B 13.14
STAAR Surgical (STAA) United States $0.882B 0.00
Pro-Dex (PDEX) United States $0.131B 14.30